Tina

Equibles does not estimate personal net worth.

Get an email with a short summary when LENZ Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get LENZ alerts

About Tina

Tina has spoken on 1 earnings call across 1 company, most recently for LENZ Therapeutics, Inc. on October 29, 2026. LENZ Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at LENZ Therapeutics, Inc. includes Daniel Chevallard (CEO and CFO), Kimberlee C. Drapkin (CEO, CFO, Chief Accounting Officer and Board Member), Jeff George (Chairman and Board Member) and 7 others.

Tina on recent calls

“Good morning, ladies and gentlemen, and welcome to the Lens Therapeutics third quarter 2026 financial results conference call. At this time, all participants are in a listen-only mode.”

Other, Lenz Therapeutics Third Quarter 2026 Financial Results and Business Update · October 29, 2026

Affiliation history

LENZ Therapeutics, Inc. (LENZ)
Transcript header (unverified)

Current

Company network

LENZ Therapeutics, Inc.

LENZ

Current role

Biotechnology · Healthcare

1 appearance Latest appearance 2026-10-29

View calls and events

Leadership on record at LENZ Therapeutics, Inc.

Daniel Chevallard CEO, CFO
Kimberlee C. Drapkin CEO, CFO, Chief Accounting Officer, Board Member
Jeff George Chairman, Board Member
Mr. George Chairman
Katherine V. Stultz COO
Continuing Directors Board Member
Frederic Guerard Board Member
James McCollum Board Member
Shelley Thunen Board Member
Zach Scheiner Board Member

Recent activity

Earnings call Lenz Therapeutics Third Quarter 2026 Financial Results and Business Update LENZ Therapeutics, Inc. (LENZ)
2026-10-29